Cite
Loss of XIAP sensitizes colon cancer cells to PPARgamma independent antitumor effects of troglitazone and 15-PGJ2.
MLA
Qiao, Liang, et al. “Loss of XIAP Sensitizes Colon Cancer Cells to PPARgamma Independent Antitumor Effects of Troglitazone and 15-PGJ2.” Cancer Letters, vol. 268, no. 2, Sept. 2008, pp. 260–71. EBSCOhost, https://doi.org/10.1016/j.canlet.2008.04.003.
APA
Qiao, L., Dai, Y., Gu, Q., Chan, K. W., Ma, J., Lan, H. Y., Zou, B., Rocken, C., Ebert, M. P. A., & Wong, B. C. Y. (2008). Loss of XIAP sensitizes colon cancer cells to PPARgamma independent antitumor effects of troglitazone and 15-PGJ2. Cancer Letters, 268(2), 260–271. https://doi.org/10.1016/j.canlet.2008.04.003
Chicago
Qiao, Liang, Yun Dai, Qing Gu, Kwok Wah Chan, Juan Ma, H Y Lan, Bing Zou, Christoph Rocken, Matthias P A Ebert, and Benjamin C Y Wong. 2008. “Loss of XIAP Sensitizes Colon Cancer Cells to PPARgamma Independent Antitumor Effects of Troglitazone and 15-PGJ2.” Cancer Letters 268 (2): 260–71. doi:10.1016/j.canlet.2008.04.003.